Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The norepinephrine transporter gene is a candidate gene for panic disorder

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Accurate motor mapping in awake common marmosets using micro-electrocorticographical stimulation and stochastic threshold estimation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Aberrant Wnt signaling pathway in medial temporal lobe structures of Alzheimer's disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Epilepsy and other central nervous system diseases in atypical autism: a case control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Natarbejde og komplikationer i graviditeten

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Occupational exposures and exacerbations of asthma and COPD-A general population study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. How to schedule night shift work in order to reduce health and safety risks

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Fetal exposure to paternal smoking and semen quality in the adult son

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Panic disorder (PD) is an anxiety disorder characterized by recurrent panic attacks with a lifetime prevalence of 4.7%. Genetic factors are known to contribute to the development of the disorder. Several lines of evidence point towards a major role of the norepinephrine system in the pathogenesis of PD. The SLC6A2 gene is located on chromosome 16q12.2 and encodes the norepinephrine transporter (NET), responsible for the reuptake of norepinephrine into presynaptic nerve terminals. The aim of the present study was to analyze genetic variants located within the NET gene for association with PD. The case-control sample consisted of 449 patients with PD and 279 ethnically matched controls. All cases fulfilled the ICD-10 diagnostic criteria for PD. Genotyping was performed using the Sequenom platform (Sequenom, Inc, San Diego, USA). To test for allelic and haplotypic association, the PLINK software was used, and COMBASSOC was applied to test for gene-wise association. After quality control 29 single nucleotide polymorphisms (SNPs) spanning the gene-region were successfully analyzed. Seven SNPs located within the 5' end of the gene were significantly associated with PD. Furthermore, the NET gene showed overall evidence for association with the disease (P = 0.000035). In conclusion, the present study indicates that NET could be a susceptibility gene for PD.
Original languageEnglish
JournalJournal of Neural Transmission
Volume118
Issue number6
Pages (from-to)969-76
Number of pages8
ISSN0300-9564
DOIs
Publication statusPublished - 2011

ID: 34673117